Citadel Advisors’s UpHealth, Inc. UPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,250
Closed -$1.23K 15746
2023
Q3
$1.23K Buy
+1,250
New +$1.83K ﹤0.01% 13897
2023
Q1
Sell
-12,570
Closed -$20.5K 16240
2022
Q4
$20.5K Sell
12,570
-4,620
-27% -$18K ﹤0.01% 13130
2022
Q3
$91K Sell
17,190
-1,580
-8% -$9.44K ﹤0.01% 11171
2022
Q2
$111K Buy
18,770
+2,300
+14% +$17.9K ﹤0.01% 11315
2022
Q1
$194K Buy
16,470
+1,030
+7% +$22.8K ﹤0.01% 11581
2021
Q4
$346K Buy
15,440
+670
+5% +$15.5K ﹤0.01% 10603
2021
Q3
$467K Buy
14,770
+4,540
+44% +$237K ﹤0.01% 10044
2021
Q2
$690K Sell
10,230
-1,840
-15% -$173K ﹤0.01% 9277
2021
Q1
$1.21M Buy
12,070
+190
+2% +$19.6K ﹤0.01% 7629
2020
Q4
$1.3M Buy
+11,880
New +$1.22M ﹤0.01% 6236

Other funds holding UPH

Citadel Advisors's UPH Position: Q4 2023 in Review

Citadel Advisors sold out of UpHealth, Inc. (UPH) in Q4 2023, closing a stake of 8,416 shares — an estimated $8.25K sold.

Citadel Advisors first reported a position in UPH in Q4 2020 and held it in 7 quarters. The position peaked at $3.1M in Q4 2020. 5 funds tracked by Wall St. Rank hold UPH as of Q4 2023.

  • Citadel Advisors reported no remaining UpHealth, Inc. position as of Q4 2023 after selling out during the quarter.
  • Citadel Advisors sold 8,416 UpHealth, Inc. shares in Q4 2023, an estimated $8.25K.
  • Citadel Advisors first reported a position in UpHealth, Inc. in Q4 2020 and held it in 7 quarters.
  • Citadel Advisors's UpHealth, Inc. position peaked at $3.1M in Q4 2020.
  • 5 funds tracked by Wall St. Rank held UpHealth, Inc. as of Q4 2023.

Based on Citadel Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.